Status:
UNKNOWN
Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
Surgery--Complications
Cardiac Valve Disease
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
This is a randomized clinical trial, double-blind, placebo-controlled study with the goal to assess the influence of using N-AcetylCysteyn (NAC) for prevention of AKI (Acute Kidney Injury) in post ope...
Detailed Description
Acute kidney injury (AKI) is a serious complication after cardiovascular surgery. Pharmacologic interventions to prevent postoperative AKI have been, in general, unsuccessful. N-Acetylcystein (NAC) is...
Eligibility Criteria
Inclusion
- Adults
- Both sex
- Elective replacement valve (mitral or aortic) procedure
Exclusion
- Chronic dialysis patients
- Emergency procedures
- Percutaneous procedures
- Pregnants
- Oncologic patients
Key Trial Info
Start Date :
March 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 15 2020
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT03440268
Start Date
March 15 2018
End Date
March 15 2020
Last Update
March 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
José Jayme Galvão de Lima
São Paulo, Brazil, 05403-900